CX3CR1 expression and megakaryocytic series assessment on bone marrow biopsies in acquired aplastic anemia. Correlations with hematological parameters.

1. Zeng Y, Katsanis E. The complex pathophysiology of acquired aplastic anemia. Clin Exp Immunol. 2015;180(3):361-70. DOI: 10.1111/cei.1260510.1111/cei.12605444976525683099Search in Google Scholar

2. Fong AM, Alam SM, Imai T, Haribabu B, Patel DD. CX3CR1 tyrosine sulfation enhances fractalkine-induced cell adhesion. J Biol Chem. 2002;277(22):19418-23. DOI: 10.1074/jbc.M20139620010.1074/jbc.M20139620011909868Search in Google Scholar

3. Kobayashi T, Okamoto S, Iwakami Y, Nakazawa A, Hisamatsu T, Chinen H, et al. Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes. Inflamm Bowel Dis. 2007;13(7):837-46. DOI: 10.1002/ibd.2011310.1002/ibd.2011317285595Search in Google Scholar

4. Jamieson WL, Shimizu S, D’Ambrosio JA, Meucci O, Fatatis A. CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism. Cancer Res. 2008;68(6):1715-22. DOI: 10.1158/0008-5472.CAN-07-131510.1158/0008-5472.CAN-07-1315266973518339851Search in Google Scholar

5. D´Haese JG, Demir IE, Friess H, Ceyhan GO. Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential. Expert Opin Ther Targets. 2010;14(2):207-19. DOI: 10.1517/1472822090354026510.1517/1472822090354026520055718Search in Google Scholar

6. Olsson B, Ridell B, Carlsson L, Jacobsson S, Wadenvik H. Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1. Blood. 2008;112(4):1078-84. DOI: 10.1182/blood-2008-02-13940210.1182/blood-2008-02-13940218519809Search in Google Scholar

7. Ferretti E, Bertolotto M, Deaglio S, Tripodo C, Ribatti D, Audrito V, et al. A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment. Leukemia. 2011;25(8):1268-77. DOI: 10.1038/leu.2011.8810.1038/leu.2011.8821546901Search in Google Scholar

8. Tsai WH, Shih CH, Feng SY, Chang SC, Lin YC, Hsu HC. Role of CX3CL1 in the chemotactic migration of all-trans retinoic acid-treated acute promyelocytic leukemic cells toward apoptotic cells. J Chin Med Assoc. 2014;77(7):367-73. DOI: 10.1016/j.jcma.2014.04.00810.1016/j.jcma.2014.04.00824908182Search in Google Scholar

9. Andreasson U, Ek S, Merz H, Rosenquist R, Andersen N, Jerkeman M, et al. B cell lymphomas express CX3CR1 a non-B cell lineage adhesion molecule. Cancer Lett. 2008;259(2):138-45. DOI: 10.1016/j.canlet.2007.10.03110.1016/j.canlet.2007.10.03118060687Search in Google Scholar

10. Zhao M, Perry JM, Marshall H, Venkatraman A, Qian P, He XC, et al. Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells. Nat Med. 2014;20(11):1321-6. DOI: 10.1038/nm.370610.1038/nm.370625326798Search in Google Scholar

11. Bruns I, Lucas D, Pinho S, Ahmed J, Lambert MP, Kunisaki Y, et al. Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion. Nat Med. 2014;20(11):1315-20. DOI: 10.1038/nm.370710.1038/nm.3707425887125326802Search in Google Scholar

12. Nakamura-Ishizu A, Takubo K, Fujioka M, Suda T. Megakaryocytes are essential for HSC quiescence through the production of thrombopoietin. Biochem Biophys Res Commun. 2014;454(2):353-7. DOI: 10.1016/j.bbrc.2014.10.09510.1016/j.bbrc.2014.10.09525451253Search in Google Scholar

13. Heazlewood SY, Neaves RJ, Williams B, Haylock DN, Adams TE, Nilsson SK. Megakaryocytes co-localise with hemopoietic stem cells and release cytokines that up-regulate stem cell proliferation. Stem Cell Res. 2013;11(2):782-92. DOI: 10.1016/j.scr.2013.05.00710.1016/j.scr.2013.05.00723792434Search in Google Scholar

14. Maciejewski JP, Hibbs JP, Anderson S, Katevas P, Young NS. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure. Exp Hematol 1994; 22(11): 1102–10.Search in Google Scholar

15. Melenhorst JJ, Van Krieken JH, Dreef E, Landegent JE, Willemze R, Fibbe WE. T cells selectively infiltrate bone marrow areas with residual haemopoiesis of patients with acquired aplastic anaemia. Br J Haematol 1997; 99(3): 517–9. DOI: 10.1046/j.1365-2141.1997.4353245.x10.1046/j.1365-2141.1997.4353245.x9401058Search in Google Scholar

16. Ostuni MA, Guellec J, Hermand P, Durand P, Combadiere C, Pincet F, et al. CX3CL1, a chemokine finely tuned to adhesion: critical roles of the stalk glycosylation and the membrane domain. Biol Open. 2014;3(12):1173-82. DOI: 10.1242/bio.2014984510.1242/bio.20149845426575525395671Search in Google Scholar

17. Fraticelli P, Sironi M, Bianchi G, D´Ambrosio D, Albanesi C, Stoppacciaro A, et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 2001; 107(9): 1173–81. DOI: 10.1172/JCI1151710.1172/JCI1151720927611342581Search in Google Scholar

18. Yoneda O, Imai T, Nishimura M, Miyaji M, Mimori T, Okazaki T, et al. Membrane-bound form of fractalkine induces IFN-gamma production by NK cells. Eur J Immunol 2003; 33(1): 53–8. DOI: 10.1002/immu.20039000710.1002/immu.20039000712594832Search in Google Scholar

19. Kordasti S, Marsh J, Al-Khan S, Jiang J, Smith A, Mohamedali A, et al. Functional characterization of CD4+ T cells in aplastic anemia. Blood. 2012;119(9):2033-43. DOI: 10.1182/blood-2011-08-36830810.1182/blood-2011-08-36830822138514Search in Google Scholar

20. White GE, Greaves DR. Fractalkine: a survivor’s guide: chemokines as antiapoptotic mediators. Arterioscler Thromb Vasc Biol. 2012;32(3):589-94. DOI: 10.1161/ATVBAHA.111.23741210.1161/ATVBAHA.111.23741222247260Search in Google Scholar

21. Ren J, Hou XY, Ma SH, Zhang FK, Zhen JH, Sun L, et al. Elevated expression of CX3C chemokine receptor 1 mediates recruitment of T cells into bone marrow of patients with acquired aplastic anaemia. J Intern Med. 2014;276(5):512-24. DOI: 10.1111/joim.1221810.1111/joim.1221824528288Search in Google Scholar

22. Morita Y, Matsuda M, Hanamoto H, Shimada T, Tatsumi Y, Maeda Y, et al. A perforin/granzyme-positive MDS-derived T cell line, K2-MDS, induces apoptosis in CD34+ cells through the fractalkine-CX3CR1 system. Clin Immunol. 2004;113(1):109-16. DOI: 10.1016/j.clim.2004.05.00510.1016/j.clim.2004.05.00515380536Search in Google Scholar

23. Risitano AM. Aplastic Anemia: Alternative Immunosuppressive Treatments and Eltrombopag. A report from the 2014 EBMT Educational Meeting from the Severe Aplastic Anaemia and Infectious Diseases Working Parties. Curr Drug Targets. 2015; 14(3):206-12.Search in Google Scholar